Innovative Technologies
Enhancing the performance of antibodies by stripping them of fucose, linking antibodies to their drug loads at multiple targeted sites, testing the recombinant protein’s immunogenicity and function in-vitro, increasing productivity to unprecedented levels, or even boosting your viral vector or vaccine – our innovative technologies make those wishes your reality.
Genetic Glyco-Engineering/
ADCC (GlymaxX®)
Virus Production
Cell Lines
Viral Vector
Technologies
DirectedLuck® Transposase
with Epigenetic Targeting
Immunogenicity/-function Testing (Human Artificial Lymph Node)
Quality Management
The high quality of ProBioGen’s products relies on the synergetic improvement of each individual process step. Our quality management system is based on standard DIN EN ISO 9001:2015 and specifically tailored to serve our client's individual requirements. ProBioGen holds a manufacturing authorization for GMP compliant manufacturing and batch release of biotechnological drug substances.

Your Objectives
Are you looking to enhance your program or are you just curious about our company, services, and technologies? Connect with our team and we will get back to you shortly.